Blackstone-Backed Drug Tech Co. Raises $823M In IPO

The Blackstone Group LP-backed drug delivery company Catalent Inc. raised $822.7 million Thursday in its public debut, pricing in the middle of its range at $20.50 per share as it joined the parade of health care companies making initial public offerings ...read more

  • Tags: